Wednesday, August 08, 2007

Department Of Health And Children Statement On Misdiagnosis Of Breast Cancer, Ireland

The Minister for Health and Children, Mary Harney, TD, was made aware in recent days by the HSE about the misdiagnosis of breast cancer in a woman who resides in the Mid-Western region. She is aware that the woman presented to Barrington's Hospital, Limerick, initially in 2005, and again in 2007, and that there is specific concern surrounding two pathology tests performed in University College Hospital, Galway during that time.

The Minister apologises to this woman and her family for the distress and trauma caused to them.
The Minister has decided that a prompt investigation is required into all aspects of this woman's care, and any other issues that may arise, in line with best international practice following reports of adverse clinical events. She has asked officials to examine the most appropriate and effective mechanism for this investigation, including the option of a statutory inquiry under the Commissions of Investigations Act, 2004, which would require Government approval.
She also intends that the Medical Council be fully briefed on the circumstances surrounding this case and to request it to examine relevant aspects under its own statutory powers.
Role of HIQA
The powers of the recently established Health Information and Quality Authority (HIQA) extend to publicly-provided services. HIQA is, therefore, in a position to undertake an inquiry only into the components of this woman's care provided in HSE-funded institutions.
The Minister has consulted with HIQA on how a prompt and wide ranging review of all aspects of this woman's care, including those components provided in the independent hospital sector can be progressed. She plans to draw on the expertise of HIQA to advise on and support any resulting process.
HIQA is taking part in the Commission on Patient Safety, established by the Minister in January and chaired by Dr Deirdre Madden. Its work, which has an 18 month timeframe, includes developing proposals for greater accountability within our health system for performance in relation to patient safety, more effective reporting of adverse clinical events and complaints in order to learn from them, and a statutory system of licensing of all providers of health care.
The best advice made available to the Minister has been that a licensing system for independent providers should be in place in order for HIQA to carry out investigations into non-publicly-funded health care provision.
Standards for Breast Cancer Care
In May this year, the Minister approved "Quality Assurance Standards for Symptomatic Breast Disease Services in Ireland", which were prepared by a multi-disciplinary expert group and submitted to the Minister by HIQA. The Minister accepts the strong advice of HIQA and the expert group that care provided in accordance with these standards enhances quality reduces the likelihood of clinical errors and improves a woman's chance of surviving her cancer and maximising her quality of life.
These standards require significant reorganisation of breast cancer services to ensure that each centre providing breast cancer care
-- Manages a minimum of 150 new cases each year
-- Ensures that such care is provided by a team made up of a surgeon, a radiologist and a pathologist
-- Has a minimum of three consultants in each of these specialties
The Department of Health and Children has asked the HSE to progress the full and prompt implementation of these standards. HIQA will monitor and review the HSE's implementation of these standards and report directly to the Minister.
The Minister calls on hospitals in the independent sector and on the organisations that fund and insure care in that sector to take immediate steps to ensure that breast cancer services provided in non-HSE funded institutions are in compliance with these standards.

Large European Study: Increased Cure Of Breast Cancer With Extra "boost" Irradiation After Surgery

A large European study shows that an extra "boost dose" of irradiation after surgery for breast cancer improves the chance of cure. That is the conclusion of Professor Harry Bartelink, from the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital (NKI-AVL) in Amsterdam, and his colleagues in the August issue of the top oncology journal Journal of Clinical Oncology.

During this randomized study, more than 5000 breast cancer patients were followed for 10 years. The research is a collaboration between the NKI-AVL and 32 other European research institutes, lead by Professor Harry Bartelink.

In the Netherlands, about 1 in 9 women get breast cancer. Breast cancer is therefore the most common cancer in women. Approximately 80% of the women are treated with breast conserving surgery.


Professor Harry Bartelink and his colleagues followed breast cancer patients who received two doses of irradiation after surgery: a dose of 50 Gy, followed by an extra "boost" dose of 16 Gy. The boost dose lead to a 40% reduction in the chance of tumor recurrence after breast conserving surgery. The largest gain was shown for young women with breast cancer. Another important point is that with this treatment more than 80% of the patients are alive at 10 years after treatment.


Bartelink: "The favourable treatment results are partly due to the strict quality control that the participating centers had to adhere to. The outcome of this trial has lead to a worldwide change in the treatment policy for women with breast cancer".

In a new Dutch collaboration the Professor of Radiotherapy has started a large study where he hopes to further improve the treatment results for young women with breast cancer. At the same time, ways to use modern molecular techniques for predicting sensitivity to radiation are being investigated.


NETHERLANDS CANCER INSTITUTE
Plesmanlaan 121
1066 CX Amsterdam
http://www.nki.nl